Yong Wen, Ph.D. - Publications

Affiliations: 
2001 The University of Texas Graduate School of Biomedical Sciences at Houston 
Area:
Oncology, Molecular Biology, Cell Biology

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Jia L, Tian H, Sun S, Hao X, Wen Y. EID3 inhibits the osteogenic differentiation of periodontal ligament stem cells and mediates the signal transduction of TAZ-EID3-AKT/MTOR/ERK. Biochimica Et Biophysica Acta. Molecular Cell Research. 1871: 119662. PMID 38216090 DOI: 10.1016/j.bbamcr.2024.119662  0.311
2021 Tian H, Chen X, Zhang Y, Wang Y, Fu X, Gu W, Wen Y. Dioscin inhibits SCC15 cell proliferation via the RASSF1A/MST2/YAP axis. Molecular Medicine Reports. 23. PMID 33786612 DOI: 10.3892/mmr.2021.12053  0.342
2020 Wang Y, Zhang Y, Feng X, Tian H, Fu X, Gu W, Wen Y. Metformin inhibits mTOR and c-Myc by decreasing YAP protein expression in OSCC cells. Oncology Reports. PMID 33650651 DOI: 10.3892/or.2020.7909  0.317
2018 Li A, Gu K, Wang Q, Chen X, Fu X, Wang Y, Wen Y. Epigallocatechin-3-gallate affects the proliferation, apoptosis, migration and invasion of tongue squamous cell carcinoma through the hippo-TAZ signaling pathway. International Journal of Molecular Medicine. PMID 30106116 DOI: 10.3892/ijmm.2018.3818  0.302
2018 Chen X, Gu W, Wang Q, Fu X, Wang Y, Xu X, Wen Y. C-MYC and BCL-2 mediate YAP-regulated tumorigenesis in OSCC. Oncotarget. 9: 668-679. PMID 29416644 DOI: 10.18632/oncotarget.23089  0.37
2017 Wen Y, Ji Y, Zhang Y, Jiang B, Tang C, Wang Q, Chen X, Jia L, Gu W, Xu X. Knockdown of Yes-Associated Protein Induces the Apoptosis While Inhibits the Proliferation of Human Periodontal Ligament Stem Cells through Crosstalk between Erk and Bcl-2 Signaling Pathways. International Journal of Medical Sciences. 14: 1231-1240. PMID 29104479 DOI: 10.7150/ijms.20504  0.308
2016 Xu Y, Chen B, Zheng S, Wen Y, Xu A, Xu K, Li B, Liu C. IgG silencing induces apoptosis and suppresses proliferation, migration and invasion in LNCaP prostate cancer cells. Cellular & Molecular Biology Letters. 21: 27. PMID 28536629 DOI: 10.1186/s11658-016-0029-6  0.415
2016 Xu Y, Zheng S, Chen B, Wen Y, Zhu S. Sodium phenylbutyrate antagonizes prostate cancer through the induction of apoptosis and attenuation of cell viability and migration. Oncotargets and Therapy. 9: 2825-2833. PMID 27274278 DOI: 10.2147/OTT.S101794  0.357
2015 Pradeep S, Huang J, Mora EM, Nick AM, Cho MS, Wu SY, Noh K, Pecot CV, Rupaimoole R, Stein MA, Brock S, Wen Y, Xiong C, Gharpure K, Hansen JM, et al. Erythropoietin Stimulates Tumor Growth via EphB4. Cancer Cell. PMID 26481148 DOI: 10.1016/J.Ccell.2015.09.008  0.532
2013 Gupta GP, Vanness K, Barlas A, Manova-Todorova KO, Wen YH, Petrini JH. The Mre11 complex suppresses oncogene-driven breast tumorigenesis and metastasis. Molecular Cell. 52: 353-65. PMID 24120666 DOI: 10.1016/j.molcel.2013.09.001  0.328
2013 Sung JS, Jochelson MS, Brennan S, Joo S, Wen YH, Moskowitz C, Zheng J, Dershaw DD, Morris EA. MR imaging features of triple-negative breast cancers. The Breast Journal. 19: 643-9. PMID 24015869 DOI: 10.1111/Tbj.12182  0.307
2013 Zhang XH, Jin X, Malladi S, Zou Y, Wen YH, Brogi E, Smid M, Foekens JA, Massagué J. Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma. Cell. 154: 1060-73. PMID 23993096 DOI: 10.1016/J.Cell.2013.07.036  0.312
2012 Wen YH, Ho A, Patil S, Akram M, Catalano J, Eaton A, Norton L, Benezra R, Brogi E. Id4 protein is highly expressed in triple-negative breast carcinomas: possible implications for BRCA1 downregulation. Breast Cancer Research and Treatment. 135: 93-102. PMID 22538771 DOI: 10.1007/S10549-012-2070-0  0.313
2011 D'Arcy C, Wen YH, Stadler ZK, Brogi E, Shia J. Synchronous breast cancers with different morphologic and molecular phenotypes occurring in Lynch syndrome: what does the heterogeneity imply? The American Journal of Surgical Pathology. 35: 1743-8. PMID 21997695 DOI: 10.1097/PAS.0b013e3182320cff  0.316
2007 Wen YH, Shi X, Chiriboga L, Matsahashi S, Yee H, Afonja O. Alterations in the expression of PDCD4 in ductal carcinoma of the breast. Oncology Reports. 18: 1387-93. PMID 17982621  0.304
2005 Shao R, Lee DF, Wen Y, Ding Y, Xia W, Ping B, Yagita H, Spohn B, Hung MC. E1A sensitizes cancer cells to TRAIL-induced apoptosis through enhancement of caspase activation. Molecular Cancer Research : McR. 3: 219-26. PMID 15831675 DOI: 10.1158/1541-7786.Mcr-04-0084  0.698
2005 Cha TL, Qiu L, Chen CT, Wen Y, Hung MC. Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth. Cancer Research. 65: 2287-95. PMID 15781642 DOI: 10.1158/0008-5472.Can-04-3250  0.648
2004 Deng J, Xia W, Miller SA, Wen Y, Wang HY, Hung MC. Crossregulation of NF-kappaB by the APC/GSK-3beta/beta-catenin pathway. Molecular Carcinogenesis. 39: 139-46. PMID 14991743 DOI: 10.1002/Mc.10169  0.442
2004 Yan DH, Wen Y, Su LK, Xia W, Wang SC, Zhang S, Gan L, Lee DF, Spohn B, Frey JA, Hortobagyi GN, Hung MC. A delayed chemically induced tumorigenesis in Brca2 mutant mice. Oncogene. 23: 1896-901. PMID 14981540 DOI: 10.1038/sj.onc.1207314  0.694
2003 Li YM, Wen Y, Zhou BP, Kuo HP, Ding Q, Hung MC. Enhancement of Bik antitumor effect by Bik mutants. Cancer Research. 63: 7630-3. PMID 14633680  0.692
2003 Wen Y, Giri D, Yan DH, Spohn B, Zinner RG, Xia W, Thompson TC, Matusik RJ, Hung MC. Prostate-specific antitumor activity by probasin promoter-directed p202 expression. Molecular Carcinogenesis. 37: 130-7. PMID 12884364 DOI: 10.1002/Mc.10129  0.547
2003 Yan DH, Abramian A, Li Z, Ding Y, Wen Y, Liu TJ, Hunt K. P202, an interferon-inducible protein, inhibits E2F1-mediated apoptosis in prostate cancer cells. Biochemical and Biophysical Research Communications. 303: 219-22. PMID 12646190  0.403
2002 Deng J, Miller SA, Wang HY, Xia W, Wen Y, Zhou BP, Li Y, Lin SY, Hung MC. beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer. Cancer Cell. 2: 323-34. PMID 12398896 DOI: 10.1016/S1535-6108(02)00154-X  0.487
2002 Ding Y, Wen Y, Spohn B, Wang L, Xia W, Kwong KY, Shao R, Li Z, Hortobagyi GN, Hung MC, Yan DH. Proapoptotic and antitumor activities of adenovirus-mediated p202 gene transfer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 8: 3290-7. PMID 12374701  0.479
2002 Lee WP, Wen Y, Varnum B, Hung MC. Akt is required for Axl-Gas6 signaling to protect cells from E1A-mediated apoptosis. Oncogene. 21: 329-36. PMID 11821945 DOI: 10.1038/sj.onc.1205066  0.655
2002 Zou Y, Peng H, Zhou B, Wen Y, Wang SC, Tsai EM, Hung MC. Systemic tumor suppression by the proapoptotic gene bik. Cancer Research. 62: 8-12. PMID 11782349  0.525
2001 Wen Y, Yan DH, Wang B, Spohn B, Ding Y, Shao R, Zou Y, Xie K, Hung MC. p202, an interferon-inducible protein, mediates multiple antitumor activities in human pancreatic cancer xenograft models. Cancer Research. 61: 7142-7. PMID 11585747  0.519
2001 Lin SY, Makino K, Xia W, Matin A, Wen Y, Kwong KY, Bourguignon L, Hung MC. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nature Cell Biology. 3: 802-8. PMID 11533659 DOI: 10.1038/Ncb0901-802  0.444
2000 Wen Y, Hu MC, Makino K, Spohn B, Bartholomeusz G, Yan DH, Hung MC. HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway. Cancer Research. 60: 6841-5. PMID 11156376  0.509
2000 Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y, Pestell RG, Hung MC. Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proceedings of the National Academy of Sciences of the United States of America. 97: 4262-6. PMID 10759547 DOI: 10.1073/Pnas.060025397  0.535
2000 Wen Y, Yan DH, Spohn B, Deng J, Lin SY, Hung MC. Tumor suppression and sensitization to tumor necrosis factor alpha-induced apoptosis by an interferon-inducible protein, p202, in breast cancer cells. Cancer Research. 60: 42-6. PMID 10646849  0.56
1999 Yan DH, Wen Y, Spohn B, Choubey D, Gutterman JU, Hung MC. Reduced growth rate and transformation phenotype of the prostate cancer cells by an interferon-inducible protein, p202. Oncogene. 18: 807-11. PMID 9989832 DOI: 10.1038/Sj.Onc.1202369  0.575
Show low-probability matches.